Approval · Notice of Compliance 9276 · 2008
MENACTRA: Notice of Compliance 9276
Issued January 8, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9276
- Date
- January 8, 2008
- Company
- Sanofi Pasteur LimitedSwiftwater, Pennsylvania, United States
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Changes to the manufacturing facility and manufacturing process
- Therapeutic class
- Active immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MENACTRA | Not yet assigned | — |
Medicinal ingredients
- MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A 4 MCG per 0.5ML
- MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C 4 MCG per 0.5ML
- MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP Y 4 MCG per 0.5ML
- MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP W-135 4 MCG per 0.5ML